Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R. The heterogeneous landscape of ALK negative ALCL. Oncotarget. 2017;8(11):18525-18536.

Khani F, Robinson BD. Precursor Lesions of Urologic Malignancies. Arch Pathol Lab Med. 2017;141(12):1615-1632.

Abate F, da Silva-Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc Natl Acad Sci U S A. 2017;114(4):764-769.

Nuovo GJ, Folcik VA, Magro C. Viral-induced Modulation of Multiple Checkpoint Proteins in Cancers. Appl Immunohistochem Mol Morphol. 2017;25(6):407-414.

Fowler F, Tyler JK. Anchoring Chromatin Loops to Cancer. Dev Cell. 2017;42(3):209-211.

Hang J-, Siddiqui MT, Ali SZ. Fine Needle Aspiration of Langerhans Cell Histiocytosis: A Cytopathologic Study of 37 Cases. Acta Cytol. 2017;61(2):96-102.

Marcus A, Koizumi J, Robinson B, Giorgadze T. Perihepatic cystic mass: Zebra or horse? Cytojournal. 2017;14:21.

Gullett JC, Westblade LF, Green DA, Whittier S, Burd EM. Closing the Brief Case: Too Beta To Be a "B". J Clin Microbiol. 2017;55(6):1973-1974.

Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, et al. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. Cell Rep. 2017;19(9):1858-1873.

Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, et al. Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients. Clin Lymphoma Myeloma Leuk. 2017;17(12):825-833.